retatrutide triple agonist glp-1 gip glucagon phase 2 results Retatrutide, a GIP, and receptor agonist, for people with type diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, 2 trial conducted in the USA ADA 2026: Retatrutide Revolution

Contact your healthcare provider within 24 hours if you experience: Persistent vomiting (more than 24 hours) preventing adequate fluid intake Severe diarrhea (more than 6 episodes daily) lasting beyond 48 hours Inability to keep down fluids despite anti-nausea measures Weight loss exceeding 23 pounds in 24 hours (likely fluid loss) Markedly reduced urine output with dark, concentrated urine New or worsening dizziness affecting daily activities or causing falls Blood glucose readings consistently above target despite usual management Seek immediate medical attention (emergency department or call 911) for: Severe, persistent abdominal pain (may indicate pancreatitis or gallbladder disease, which are labeled risks of GLP-1 medications requiring immediate evaluation and drug discontinuation) [1] Severe dizziness or fainting episodes Rapid or irregular heartbeat with chest discomfort Confusion, disorientation, or altered mental status Inability to urinate for 12+ hours Signs of acute kidney injury (decreased urine output, swelling, severe fatigue) Symptoms of hyperglycemic emergencies in diabetes patients (excessive thirst, frequent urination, fatigue, fruity breath) Patients with pre-existing kidney disease, heart failure, or those taking multiple medications affecting fluid balance should maintain closer communication with their healthcare team

Windred, D

No dose adjustments are recommended for patients with renal impairment

Palmer SC, Tendal B, Mustafa RA, et al

The primary endpoint was a change in A1C

Why GLP-1 Medications Are Gaining Attention GLP-1s (glucagon-like peptide-1 receptor agonists) help regulate appetite and blood sugar by: Reducing hunger Enhancing satiety Improving insulin secretion and slowing gastric emptying Reducing food cravings and food noise My role as a dietitian in GLP-1 use As a registered dietitian and nutritionist, I work with many clients taking Ozempic, Wegovy, Saxenda, and Mounjaro [For a list of the GLP-1 medications, see Figure 1 of this article]